Experimental HIV Vaccine has Failed to Provide Women in Southern Africa with Protection

An experimental Johnson & Johnson (J&J) HIV vaccine that uses the same technology as successful shots against Covid-19 and Ebola, has failed to provide women in Southern Africa with significant protection against the virus, researchers said on Tuesday.

The disappointing results are the latest in a long history of setbacks to the global effort to develop a safe and effective HIV vaccine